Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone level independently of obesity in elderly subjects with normal glucose tolerance

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 6, 2008, Pages 2313-2318

  Sung, Hee Choi ^a,b   You, Jin Lee ^a   Young, Joo Park ^a,b   Ki, Woong Kim ^b   Eun, Jung Lee ^a   Lim, Soo ^b   Do, Joon Park ^a   Sang, Eun Kim ^b   Kyong, Soo Park ^a   Jang, Hak C ^a,b   Bo, Youn Cho ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; RETINOL BINDING PROTEIN 4; THYROTROPIN;

AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SUBCUTANEOUS FAT; THYROID FUNCTION;

EID: 45149125047     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2536     Document Type: Article

References (43)

1. Tamori Y, Sakaue H, Kasuga M 2006 RBP4, an unexpected adipokine. Nat Med 12:30-31; discussion 31
2. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB 2005 Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356-362
3. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB 2006 Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354:2552-2563
4. Wolf G 2007 Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutr Rev 65:251-256
5. Weiping L, Qingfeng C, Shikun M, Xiurong L, Hua Q, Xiaoshu B, Suhua Z, Qifu L 2006 Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 30:283-288
6. Broch M, Vendrell J, Ricart W, Richart C, Fernandez-Real JM 2007 Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care 30:1802-1806
7. Gavi S, Stuart LM, Kelly P, Melendez MM, Mynarcik DC, Gelato MC, McNurlan MA 2007 Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol Metab 92:1886-1890
8. Lee DC, Lee JW, Im JA 2007 Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 56:327-331
9. Craig RL, Chu WS, Elbein SC 2007 Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Mol Genet Metab 90:338-344
10. Polonsky KS 2006 Retinol-binding protein 4, insulin resistance, and type 2 diabetes. N Engl J Med 354:2596-2598
11. Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, Sharma AM, Jordan J 2006 Retinol-binding protein 4 in human obesity. Diabetes 55:2805-2810
12. Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J, Xiang K 2007 Association of serum retinol binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 92:3224-3229
13. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A, Haring HU 2007 High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 30:1173-1178
14. Raila J, Henze A, Spranger J, Mohlig M, Pfeiffer AF, Schweigert FJ 2007 Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients. Kidney Int 72:505-511
15. Shin MJ, Kang SM, Jang Y, Lee JH, Oh J, Chung JH, Chung N 2007 Serum retinol binding protein 4 levels are associated with serum adiponectin levels in non-diabetic, non-obese subjects with hypercholesterolemia. Clin Chim Acta 378:227-229
16. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R 2008 Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol 125(1):41-48
17. Monzani F, Dardano A, Caraccio N 2006 Does treating subclinical hypothyroidism improve markers of cardiovascular risk? Treat Endocrinol 5:65-81
18. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW 2006 Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033-1041
19. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861-865
20. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, Bauer DC 2005 Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460-2466
21. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V 2005 Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of Internal Medicine 165:2467-2472
22. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270-278
23. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Rodgers H, Tunbridge F, Young ET 1996 The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6:155-160
24. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V 2006 Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin Endocrinol (Oxf) 65:486-491
25. Luboshitzky R, Aviv A, Herer P, Lavie L 2002 Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12:421-425
26. Kahaly GJ 2000 Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10:665-679
27. American Diabetes Association 2007 Diagnosis and classification of diabetes mellitus. Diabetes Care 30(Suppl 1):S42-S47
28. Pacini G, Bergman RN 1986 MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
30. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
31. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS 2006 Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29:2457-2461
32. WHO expert consultation 2004 Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157-163
33. Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L, Jorgensen T 2005 Small differences in thyroid functionmaybe important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90:4019-4024
34. Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, Psyrogiannis AI, Kalfarentzos FE, Kyriazopoulou VE 2006 Thyroid function in humans with morbid obesity. Thyroid 16:73-78
35. Tagliaferri M, Berselli ME, Calo G, Minocci A, Savia G, Petroni ML, Viberti GC, Liuzzi A 2001 Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res 9:196-201
36. Von Eynatten M, Lepper PM, Liu D, Lang K, Baumann M, Nawroth PP, Bierhaus A, Dugi KA, Heemann U, Allolio B, Humpert PM 2007 Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 50:1930-1937
37. Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B 2007 Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 92:1168-1171
38. Hu D, Hannah J, Gray RS, Jablonski KA, Henderson JA, Robbins DC, Lee ET, Welty TK, Howard BV 2000 Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study. Obes Res 8:411-421
39. Erikstrup C, Mortensen OH, Pedersen BK 2006 Retinol-binding protein 4 and insulin resistance. N Engl J Med 355:1393-1394; author reply 1394-1395
40. Altinova AE, Toruner FB, Akturk M, Bukan N, Cakir N, Ayvaz G, Arslan M 2006 Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clin Endocrinol (Oxf) 65:530-535
41. Saito T, Kawano T, Saito T, Ikoma A, Namai K, Tamemoto H, Kawakami M, Ishikawa SE 2005 Elevation of serum adiponectin levels in Basedow disease. Metabolism 54:1461-1466
42. Nagasaki T, Inaba M, Hiura Y, Tahara H, Kumeda Y, Shirakawa K, Onoda N, Ishikawa T, Ishimura E, Nishizawa Y 2005 Plasma levels of adiponectin and soluble thrombomodulin in hypothyroid patients with normal thyroid function following levothyroxine replacement therapy. Biomed Pharmacother 59:571-577
43. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F 2005 Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf) 62:487-491